THINNEST STRUT DES (CE Approved)
Biodegradable Polymer based Sirolimus Eluting Coronary Stent System
Introducing Superia – the next generation DES engineered to deliver Safety & Efficacy. With the proven efficacy of sirolimus, fully bioresorbable polymer and CoCr stent surface finish, safety is in Superia’s very design.
|Design:||Uniform sinusoidal cell design|
|Material:||L 605 Cobalt Chromium|
|Strut Thickness:||68 µm|
|Strut Width:||85 µm|
|Crossing profile:||1 mm|
|Guiding Catheter:||5 Fr Compatible|
Excellent clinical outcomes
Superia stent has shown excellent results in a 200 patient trial conducted across 16 centers in India. Overall MACE was only 1.54% (at 2 year FU) with late lumen of just 0.10 mm (at 6 month check angio)
For detailed study information – Click here
Engineered to Deliver Safety and Efficacy
Drug Release Kinetics
Superia has proven drug release kinetics. Initial burst release of Sirolimus followed by sustained release up to 40 days.
Strut Thickness Matters
Superia is the thinnest DES available in the market. Thin strut & polymer coating reduces injury to vessel wall and aid faster re-endothelialization thereby minimizing the risk of Thrombosis.